Holen Sie sich die Stockscreener-App
11.64
0.94%
-0.11
Handel nachbörslich:
11.64
Schlusskurs vom Vortag:
$11.75
Offen:
$11.63
24-Stunden-Volumen:
5.63M
Relative Volume:
0.56
Marktkapitalisierung:
$7.94B
Einnahmen:
$6.82B
Nettoeinkommen (Verlust:
$309.60M
KGV:
25.87
EPS:
0.45
Netto-Cashflow:
$747.20M
1W Leistung:
-1.77%
1M Leistung:
-1.52%
6M Leistung:
-10.19%
1J Leistung:
-44.83%
1-Tages-Spanne:
$11.58
$11.81
1-Wochen-Bereich:
$11.58
$11.89
52-Wochen-Spanne:
$10.82
$23.32
Avantor Inc Stock (AVTR) Company Profile
Firmenname
Avantor Inc
Sektor
Telefon
(610) 386-1700
Adresse
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Vergleichen Sie AVTR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
11.64 | 8.01B | 6.82B | 309.60M | 747.20M | 0.45 |
|
ISRG
Intuitive Surgical Inc
|
567.72 | 201.13B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
190.47 | 54.75B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
79.20 | 38.41B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
250.85 | 36.26B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
273.03 | 19.72B | 2.96B | 487.70M | 344.00M | 6.6758 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-04 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-10-30 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-10-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-29 | Herabstufung | Goldman | Buy → Neutral |
| 2025-04-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-04-28 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-17 | Herabstufung | UBS | Buy → Neutral |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-10-05 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-09-14 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-09-09 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-30 | Fortgesetzt | Raymond James | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Eingeleitet | Goldman | Buy |
| 2021-04-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-08-02 | Eingeleitet | Cleveland Research | Neutral |
| 2019-06-14 | Eingeleitet | Janney | Buy |
| 2019-06-12 | Eingeleitet | Raymond James | Outperform |
| 2019-06-11 | Eingeleitet | Goldman | Buy |
| 2019-06-11 | Eingeleitet | Guggenheim | Buy |
| 2019-06-11 | Eingeleitet | JP Morgan | Overweight |
| 2019-06-11 | Eingeleitet | Jefferies | Buy |
| 2019-06-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-06-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-11 | Eingeleitet | SunTrust | Buy |
| 2019-06-11 | Eingeleitet | UBS | Buy |
| 2019-06-11 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Avantor Inc Aktie (AVTR) Neueste Nachrichten
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor - MarketScreener
Bragar Eagel & Squire, P.C. Reminds Stockholders of Sprouts - GlobeNewswire
Avantor, Inc. (AVTR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
How Avantor Inc. stock benefits from digital adoptionPortfolio Value Report & Growth Focused Entry Reports - Newser
Is Avantor a Bargain After New Partnerships and a 45% Share Price Drop in 2025? - Yahoo Finance
Avantor (NYSE: AVTR) Securities Class Action: Johnson - GlobeNewswire
AVTR Class Action Reminder: Avantor, Inc. Investors Can Lead the Securities Class Action LawsuitContact Robbins LLP for Information - PR Newswire
Contact Levi & Korsinsky by December 29, 2025 Deadline to Join Class Action Against Avantor, Inc.(AVTR) - GlobeNewswire
Can Avantor Inc stock sustain margin levels2025 Historical Comparison & Fast Gaining Stock Strategy Reports - BỘ NỘI VỤ
ROSEN, LEADING INVESTOR COUNSEL, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 29, 2025 in Avantor, Inc. LawsuitAVTR - PR Newswire
Lost Money on Avantor, Inc. (AVTR)? Join Class Action Before December 29, 2025 – Contact Levi & Korsinsky - ACCESS Newswire
Lost Money on Avantor, Inc. (AVTR)? Join Class Action Before December 29, 2025Contact Levi & Korsinsky - Stockhouse
AVTR DEADLINE: Faruqi & Faruqi Reminds Avantor Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 29, 2025AVTR - PR Newswire
What drives Avantor Inc AVG stock priceChart Pattern Recognition & Low Entry Investment Plans - earlytimes.in
Investors in Avantor, Inc. (AVTR): Protect Your Rights – Contact Levi & Korsinsky Before December 29, 2025 - ACCESS Newswire
Investors in Avantor, Inc. (AVTR): Protect Your RightsContact Levi & Korsinsky Before December 29, 2025 - Stockhouse
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor - GlobeNewswire Inc.
Will Avantor Inc. stock outperform value peersGlobal Markets & Fast Exit and Entry Trade Guides - moha.gov.vn
Synopsys, Inc. Sued for Securities Law Violations - GlobeNewswire Inc.
Avantor, Inc. $AVTR Holdings Increased by Clarkston Capital Partners LLC - Defense World
Class Action Lawsuit Filed: Avantor, Inc. (AVTR)Join by December 29, 2025Contact Levi & Korsinsky - ACCESS Newswire
AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit - GuruFocus
AVTR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
AVTR Investors Have Opportunity to Lead Avantor, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
Avantor Sued Over Supply Chain Issues After $6.4B Deal - Law360
Avantor Investor Sues Over Alleged Hidden Competitive Struggles - Bloomberg Law News
Avantor Launches Watertown Facility to Expand Centralized Laboratory Services - Lab Manager
Avantor Announces Emmanuel Ligner as Next President and CEO (PR Newswire) - Aktiellt
Investors SueWallSt as Avantor, Inc. Faces Securities Fraud Allegations - Nasdaq
Levi & Korsinsky Notifies Avantor, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – AVTR - GlobeNewswire
Deadline Alert: Avantor, Inc. (AVTR) Shareholders Who Lost - GlobeNewswire
Contact Levi & Korsinsky by December 29, 2025 Deadline to Join Class Action Against Avantor, Inc. (AVTR) - NewMediaWire
Avantor, Inc. (AVTR) Investors: December 29, 2025 Filing Deadline in Securities Class ActionContact Lieff Cabraser - ACCESS Newswire
Avantor® Receives 2025 Edison Patent Award for Sustainable Viral Inactivation Technology - MarketScreener
Avantor (NYSE: AVTR) and Amgen win 2025 Edison Patent Award for viral inactivation - Stock Titan
Investors SueWallSt as Avantor, Inc. Faces Securities Fraud Allegations (2025-11-24) - Seeking Alpha
Avantor, Inc. Sued for Securities Law ViolationsContact - GlobeNewswire
Contact The Gross Law Firm by December 29, 2025 Deadline to Join Class Action Against Avantor, Inc.(AVTR) - cnhinews.com
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor - MarketScreener
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Avantor, Inc. - GlobeNewswire
Is Avantor Stock a Buy After the CEO Scooped Up Nearly $1 Million in Shares? - AOL.com
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Avantor, Inc. Investors to Secure Counsel Before ... - Caledonian Record
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 29, 2025 in Avantor, Inc. LawsuitAVTR - The Globe and Mail
Zacks Research Lowers Earnings Estimates for Avantor - Defense World
Envista, Alignment Healthcare, LifeStance Health Group, Avantor, and Bio-Techne Shares Are Soaring, What You Need To Know - TradingView
UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor - MarketScreener
There is no way Avantor Inc (AVTR) can keep these numbers up - Setenews
Why Avantor Inc. (AVG) stock signals breakout potentialEarnings Risk Report & Weekly Top Stock Performers List - newser.com
Finanzdaten der Avantor Inc-Aktie (AVTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.26%
2.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):